EFFECTIVENESS AND SAFETY OF PIMECROLIMUS IN TREATMENT OF ATOPIC DERMATITIS IN CHILDREN AND ADOLESCENTS
The results of treatment of 57 patients with atopic dermatitis (ATD) in age 7-18 years old with elidel cream are described. Cream was drifted on facial skin 2 times daily. Apparent effect was marked on 7-14 day. There was no any case of serious adverse events. Thus, taking to account safety and effe...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
"Paediatrician" Publishers LLC,
2008-12-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The results of treatment of 57 patients with atopic dermatitis (ATD) in age 7-18 years old with elidel cream are described. Cream was drifted on facial skin 2 times daily. Apparent effect was marked on 7-14 day. There was no any case of serious adverse events. Thus, taking to account safety and effectiveness profile, pimecrolimus can be used as a medication of first line of therapy in treatment of ATD, while lesion is located on sensitive sectors of skin.Key words: children, atopic dermatitis, pimecrolimus. |
|---|---|
| Item Description: | 1682-5527 1682-5535 |